Tobira Therapeutics, Inc.
DelistedCIK 1311596fmd_1R5C1DXBP9XNAA85K05AEEXCTKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2016, 16 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|
| Net interest income | 0 | 0 | 0 | – |
| Research and development | 8 | 12 | 12 | 25 |
| Total operating expenses | 12 | 15 | 20 | 53 |
| Operating income | (12) | (15) | (20) | (53) |
| Interest expense | 1 | 4 | 5 | 3 |
| Other non-operating income (expense) | (1) | (1) | (0) | – |
| Income before taxes | – | (19) | (24) | (54) |
| Income tax expense | – | 0 | 0 | (4) |
| Net income from continuing operations | – | (19) | (24) | (50) |
| Net income | (13) | (19) | (24) | (50) |
| Net income to common shareholders | – | (34) | (82) | – |